Evaluating direct-to-employer as an alternative access channel for manufacturers

Identifying partners, discounting, support services, and customer engagement strategy

The challenge

A large pharmaceutical manufacturer sought to evaluate how its specialty pharmacy portfolio could align with emerging direct-to-employer (DTE) models. The organization wanted to better understand the evolving DTE landscape, identify partnership opportunities, assess employer expectations, and determine the operational requirements necessary for successful implementation.

The goal was to assess direct-to-employer as a potential alternative access channel and evaluate its strategic fit based on the manufacturer’s commercial objectives, market dynamics, and access considerations.

Our approach

Acumetis conducted a comprehensive assessment of the DTE ecosystem to understand stakeholder expectations, partnership opportunities, and implementation considerations.

This included:

Leveraging our network:

  • Engaging DTE technology enablers to evaluate operational feasibility and partnership opportunities
  • Connecting with transparent pharmacy benefit managers (PBMs) to understand contracting structures and reimbursement considerations
  • Connected directly with employers and major U.S. self‑funded employer coalitions to understand economic expectations and service‑level needs for successful contracting

Building the strategy:

  • Synthesized insights from network engagements to develop a phased DTE implementation strategy
  • Focused on product fit, pricing, GTN improvement expectations, and partner deployment sequencing
  • Established a structured roadmap to support a successful DTE contracting approach

Insights were synthesized into a strategic framework focused on product fit, pricing considerations, GTN improvement opportunities, contracting strategy, and deployment planning.

The solution

Through this engagement, the client gained a clearer understanding of the evolving direct-to-employer (DTE) landscape, including the stakeholders, partnership models, and market dynamics shaping future opportunities. By engaging with key players across the ecosystem, the organization was able to identify potential partnership opportunities and better understand the capabilities required to support a successful DTE strategy.

The engagement also resulted in a detailed playbook and strategic roadmap designed to guide future decision-making. The roadmap provided a structured framework for evaluating assets, assessing potential partners, and planning a phased deployment approach with vendors and employers. These insights helped position the client to evaluate DTE opportunities more strategically while creating a practical path toward future implementation.

Why it worked

Successfully evaluating emerging commercialization models requires a deep understanding of stakeholder priorities, market dynamics, and operational realities.

By engaging organizations across the DTE ecosystem and translating those perspectives into actionable recommendations, the client gained the clarity needed to evaluate opportunities, reduce uncertainty, and make more informed strategic decisions.

The outcome

  • Developed a clear understanding of the DTE ecosystem and market dynamics
  • Identified potential partners across technology, PBM, employer, and support service organizations
  • Delivered a strategic roadmap to support implementation planning
  • Established a framework for evaluating contracting and discounting opportunities
  • Supported future GTN objectives and commercialization decisions

Commercial strategy solutions that support smarter business decisions

Commercial success requires connected thinking across brand, asset, portfolio, and enterprise priorities. We combine competitive intelligence, customer insights, market dynamics, and commercial expertise to help organizations make confident decisions from asset evaluation and portfolio strategy through launch and in-market optimization. Drawing on experience across 200+ launches, we help clients challenge assumptions, align stakeholders, and turn strategy into execution.

Looking to evaluate direct-to-employer opportunities?

Acumetis helps pharmaceutical manufacturers assess emerging commercialization models, identify strategic opportunities, and develop actionable roadmaps that support long-term success.

Stay tuned for a deeper dive into how Direct-to-Employer models are evolving from a niche access approach to a broader channel strategy.

Explore alternative access channels

Explore the strategic considerations behind alternative channel models.

Contact our team

"*" indicates required fields

Learn More

Meet the Experts:

Sureka Gattu
Sureka Gattu, PhD
Principal

Dr. Sureka Gattu combines her scientific expertise with her business acumen to help companies navigate complex regulatory landscapes and bring innovative therapies to market. She founded Iyalisai Biotech Consulting, to support pre-commercial stage companies with effective evidence generation strategies, regulatory submissions, and payer marketing.

Evan Aftosmes
Evan Aftosmes
Manager, Patient Access and Support

Evan Aftosmes is a Manager at Acumetis with expertise in innovative access strategies across immunology, cardiometabolic, and rare disease. He partners with biopharmaceutical manufacturers to design patient-centric access models, evaluate novel stakeholder partnerships, and address evolving payer, provider, employer, and patient needs. Prior to Acumetis, Evan worked in HEOR and market access reimbursement within the medical device industry. He holds an MPH from the UNC Gillings School of Global Public Health and a BS in Economics from the University of Pittsburgh.

FAQs on direct-to-employer

1. What is a direct-to-employer (DTE) strategy?

A direct-to-employer (DTE) strategy enables pharmaceutical manufacturers to engage more directly with employers and employer coalitions to support patient access, improve healthcare outcomes, and explore innovative contracting and reimbursement models.

2. Why are manufacturers evaluating direct-to-employer as an alternative access channel?

Direct-to-employer (DTE) models provide manufacturers with an opportunity to evaluate alternative contracting and distribution approaches. The potential impact varies by product and commercial objectives, requiring careful assessment of market dynamics, access considerations, and implementation trade-offs.

3. Why are pharmaceutical manufacturers evaluating direct-to-employer opportunities?

As healthcare stakeholders seek greater transparency, affordability, and value, pharmaceutical manufacturers are increasingly evaluating DTE strategies as part of broader commercial strategy and market access planning efforts.